RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert R. Alfano to Cell Line, Tumor

This is a "connection" page, showing publications Robert R. Alfano has written about Cell Line, Tumor.
Connection Strength

0.223
  1. Zhang L, Pu Y, Xue J, Pratavieira S, Xu B, Achilefu S, Alfano RR. Tryptophan as the fingerprint for distinguishing aggressiveness among breast cancer cell lines using native fluorescence spectroscopy. J Biomed Opt. 2014 Mar; 19(3):37005.
    View in: PubMed
    Score: 0.074
  2. Pu Y, Xue J, Wang W, Xu B, Gu Y, Tang R, Ackerstaff E, Koutcher JA, Achilefu S, Alfano RR. Native fluorescence spectroscopy reveals spectral differences among prostate cancer cell lines with different risk levels. J Biomed Opt. 2013 Aug; 18(8):87002.
    View in: PubMed
    Score: 0.071
  3. Pu Y, Tang GC, Wang WB, Savage HE, Schantz SP, Alfano RR. Native fluorescence spectroscopic evaluation of chemotherapeutic effects on malignant cells using nonnegative matrix factorization analysis. Technol Cancer Res Treat. 2011 Apr; 10(2):113-20.
    View in: PubMed
    Score: 0.060
  4. Russell S, Samkoe KS, Gunn JR, Hoopes PJ, Nguyen TA, Russell MJ, Alfano RR, Pogue BW. Spatial frequency analysis of anisotropic drug transport in tumor samples. J Biomed Opt. 2014 Jan; 19(1):15005.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support